Miv Therapeutics, Inc. (IVT) Tops Q1 EPS by 7c
Tweet
Share
E-mailGet Alerts IVT Hot Sheet
Join SI Premium – FREE
Miv Therapeutics, Inc. (NYSE: IVT) reported Q1 EPS of $0.04, $0.07 better than the analyst estimate of ($0.03).
For earnings history and earnings-related data on Miv Therapeutics, Inc. (IVT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Xylem names Andrea van der Berg as CFO, effective Sept. 2026
- Hesai Group (HSAI) Tops Q1 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
